लोड हो रहा है...

Passive immunotherapies targeting Aβ and tau in Alzheimer's disease

Amyloid-β (Aβ) and tau proteins currently represent the two most promising targets to treat Alzheimer's disease. The most extensively developed method to treat the pathologic forms of these proteins is through the administration of exogenous antibodies, or passive immunotherapy. In this review,...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Neurobiol Dis
मुख्य लेखकों: Plotkin, Steven S., Cashman, Neil R.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: The Authors. Published by Elsevier Inc. 2020
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7365083/
https://ncbi.nlm.nih.gov/pubmed/32682954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2020.105010
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!